K.J. Harrison & Partners’s Merck MRK Stock Holding History

K.J. Harrison & Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,900	Closed	-$3.57M	–	252
2025 Q4	$3.57M	Sell	33,900 -6,200	-15%	-$582K	0.47%	63
2025 Q3	$3.59M	Buy	40,100 +31,950	+392%	+$2.63M	0.51%	57
2025 Q2	$645K	Buy	+8,150	New	+$648K	0.11%	143
2023 Q3	–	Sell	-4,050	Closed	-$466K	–	175
2023 Q2	$466K	Buy	+4,050	New	+$460K	0.08%	167
2020 Q4	–	Sell	-21,012	Closed	-$1.67M	–	301
2020 Q3	$1.67M	Buy	+21,012	New	+$1.65M	0.34%	98
2018 Q1	–	Sell	-10,532	Closed	-$566K	–	182
2017 Q4	$566K	Buy	+10,532	New	+$584K	0.19%	122
2015 Q2	–	Sell	-57,692	Closed	-$3.16M	–	190
2015 Q1	$3.16M	Sell	57,692 -78,600	-58%	-$4.45M	0.92%	35
2014 Q4	$7.38M	Hold	136,292	–	–	2.13%	12
2014 Q3	$7.71M	Hold	136,292	–	–	2.16%	11
2014 Q2	$7.52M	Hold	136,292	–	–	2.15%	9
2014 Q1	$7.35M	Sell	136,292 -315	-0.2%	-$16.3K	2.18%	10
2013 Q4	$6.94M	Buy	136,607 +315	+0.2%	+$14.4K	2.04%	14
2013 Q3	$6.19M	Hold	136,292	–	–	2.25%	10
2013 Q2	$6.04M	Buy	+136,292	New	+$6.09M	2.43%	9

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

K.J. Harrison & Partners's MRK Position: Q1 2026 in Review

K.J. Harrison & Partners sold out of Merck (MRK) in Q1 2026, closing a stake of 33,900 shares — an estimated $3.57M sold.

K.J. Harrison & Partners first reported a position in MRK in Q2 2013 and held it in 14 quarters. The position peaked at $7.71M in Q3 2014. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

K.J. Harrison & Partners reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
K.J. Harrison & Partners sold 33,900 Merck shares in Q1 2026, an estimated $3.57M.
K.J. Harrison & Partners first reported a position in Merck in Q2 2013 and held it in 14 quarters.
K.J. Harrison & Partners's Merck position peaked at $7.71M in Q3 2014.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on K.J. Harrison & Partners's 13F filing for Q1 2026, filed 28 Apr 2026.